Your Guide to AAT-AD/PD™ 2020

COVID-19 Update

For AAT-AD/PD™, the science of finding solutions for patients with Alzheimer’s and Parkinson’s diseases has always been our DNA. Even in difficult times, the science remains our first priority. Exchanging scientific data and sharing novel insights must not wait.

As the news about the COVID-19 outbreak continues to evolve and some major events are being cancelled or postponed, we are happy to announce that the AAT-AD/PD™ 2020 will not be postponed. For the first time, AAT-AD/PD™ 2020 will be held as an entirely virtual meeting and can be attended from anywhere in the world.

You will be able to connect with other participants, visit virtual exhibitor booths, attend online sessions, view e-posters and receive CME credits, exactly as you would at a regular conference.

Access to the AAT-AD/PD™ virtual conference  is included in the registration of all participants who are already registered. The online sessions will be available until 30 June.

Click here to find answers to the most frequently asked questions about the Virtual Meeting.


The official language of AAT-AD/PD™ 2020  is English.


For more information about CME/CPD Accreditation of this medical event, click here.

Kenes International | Organizers of Congresses | S.A.Rue François-Versonnex 71207 | Geneva, Switzerland